Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06412510 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Final enrollment: 1 participants — 5% of the 22 planned Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 6 of 20 entries
    • Site details revised
  2. Minor Primary and study completion dates: Mar 10, 2026 to Sep 2026v9
  3. Notable Start date: Jul 23, 2024 to Sep 5, 2025
    • Primary and study completion dates: Nov 10, 2025 to Mar 10, 2026
    v8
  4. Minor Primary and study completion dates: Aug 10, 2025 to Nov 10, 2025
    • Eligibility criteria expanded, about 18 words
    v7
  5. Notable Primary and study completion dates: Feb 10, 2025 to Aug 10, 2025v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2024 to Jul 23, 2024
    • Site details revised
    v5
  2. Minor Enrollment target: 30 to 22
    • Secondary endpoints: 21 to 20
    v4
  3. Notable Start date: Jul 1, 2024 to Oct 1, 2024v3
  4. Notable Start date: Jun 1, 2024 to Jul 1, 2024v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to see whether participants who are assigned to a multimodal prehabilitation intervention during chemotherapy are able to adhere with exercise and nutrition program to prepare for their cancer surgery.
Trial Details
NCT Number NCT06412510
Lead Sponsor Case Comprehensive Cancer Center
Conditions
(from sponsor)
Ovarian Cancer, Epithelial Ovarian Cancer, Pancreatic Adenocarcinoma
Related terms Carcinoma, Ovarian Epithelial, Ovarian Neoplasms
Enrollment 1 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov